← Leaderboards
Elaine R Mardis
Washington University
$11,835,945
Attributed
$17,533,630
Total exposure
8
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $14.5M · FY2010–25$20M$15M$10M$5M$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$28,455,034 · 10
By mechanism
U54$14,705,311 · 3
R01$6,361,831 · 3
U01$5,621,716 · 2
U10$1,598,832 · 1
P30$167,344 · 1
Top collaborators
- Ann-Kathrin Eisfeld6 shared
- Timothy P Cripe5 shared
- Paul Joseph Goodfellow5 shared
- Christine H Chung3 shared
- Adam Paul Dicker3 shared
- Matthew J Ellis3 shared
- H Leighton Grimes3 shared
- Heather D Hampel3 shared
Most similar at Washington University
Same institution · by research overlap
- Li Ding$30,836,856
- Bettina F. Drake$4,193,535
- Sanjay Jain$27,367,157
- Jingqin Luo$2,426,601
- Linda Joy Pike$7,823,237
Others in their field
Top investigators on “Mutation”
- Richard A Gibbs · Baylor College Of Medicine$276,143,183
- David Heimbrook · Leidos Biomedical Research, Inc.$175,834,894
- Randall J Bateman · Washington University$154,391,630
- Eric Martin McDade · Washington University$96,219,353
- Stacey Gabriel · Massachusetts Institute Of Technology$95,141,374
- Tatiana M. Foroud · Indiana Univ-Purdue Univ At Indianapolis$93,475,056
Research focus
MutationMalignant NeoplasmsBaseGenomicsResponseMolecularGenomeCohortSamplingDesignTumorCellsResearch PersonnelGeneticBiologicalPharmaceutical PreparationsMedicalGene MutationResistanceClinical TrialsLaboratoriesUniversitiesTechnologyModality
Grant awards (29)
Towards an inclusive genomic risk classification for acute myeloid leukemia (AML)$652,141
R01 · FY2025 · CA
Towards an inclusive genomic risk classification for acute myeloid leukemia (AML)$622,018
R01 · FY2024 · CA
Understanding Treatment Response Patterns And Therapy Resistance In IDH-Mutant AML$617,933
R01 · FY2024 · CA
Towards an inclusive genomic risk classification for acute myeloid leukemia (AML)$687,428
R01 · FY2023 · CA
Understanding Treatment Response Patterns And Therapy Resistance In IDH-Mutant AML$637,871
R01 · FY2023 · CA
Understanding Treatment Response Patterns And Therapy Resistance In IDH-Mutant AML$664,967
R01 · FY2022 · CA
Combined NGS tumor-based detection of germline Lynch syndrome mutations and prognostic classification of endometrial cancers$443,629
R01 · FY2022 · CA
Admin-Core-001$172,073
U54 · FY2022 · CA
Diversity Supplement: Hernandez-Aguirre- Cripe U54$172,073
U54 · FY2022 · CA
Admin. Suppl. for NCI CCSG/Moonshot Grant to Develop Immune Radiation Response Index (iRRI) for Immune Cells from Normal and Tumor Microenvironments$167,344
P30 · FY2022 · CA
Combined NGS tumor-based detection of germline Lynch syndrome mutations and prognostic classification of endometrial cancers$481,481
R01 · FY2021 · CA
Childhood high-risk sarcoma derived human satellite (HSAT) and endogenous retroviral (ERV) RNAs in immunosuppression and inflammation$202,800
U54 · FY2021 · CA
Combined NGS tumor-based detection of germline Lynch syndrome mutations and prognostic classification of endometrial cancers$503,159
R01 · FY2020 · CA
Pediatric Ohio-New York Cancer (Peds-ONC) Immunotherapy Center$137,060
U54 · FY2020 · CA
Pediatric Ohio-New York Cancer (Peds-ONC) Immunotherapy Center$10,242,127
U54 · FY2019 · CA
Core B: Genomics and Immune Monitoring Shared Resource Core$3,779,178
U54 · FY2019 · CA · contact PI
Combined NGS tumor-based detection of germline Lynch syndrome mutations and prognostic classification of endometrial cancers$519,730
R01 · FY2019 · CA
Combined NGS tumor-based detection of germline Lynch syndrome mutations and prognostic classification of endometrial cancers$531,474
R01 · FY2018 · CA
Integrated Translational Genoproteomics Center at Washington University$428,007
U10 · FY2016 · CA
Integrated Translational Genoproteomics Center at Washington University$570,826
U10 · FY2015 · CA
Integrated Translational Genoproteomics Center at Washington University$599,999
U10 · FY2014 · CA
NEXT GENERATION SEQUENCING ADD-ON-PHARMACOGENOMICS RESEARCH NETWROK (PGRN)$321,522
U01 · FY2014 · GM · contact PI
NEXT GENERATION SEQUENCING ADD-ON-PHARMACOGENOMICS RESEARCH NETWROK (PGRN)$547,579
U01 · FY2013 · GM · contact PI
NEXT GENERATION SEQUENCING ADD-ON-PHARMACOGENOMICS RESEARCH NETWROK (PGRN)$572,671
U01 · FY2012 · GM · contact PI
NEXT GENERATION SEQUENCING ADD-ON-PHARMACOGENOMICS RESEARCH NETWROK (PGRN)$577,848
U01 · FY2011 · GM · contact PI
NEXT GENERATION SEQUENCING ADD-ON-PHARMACOGENOMICS RESEARCH NETWROK (PGRN)$594,799
U01 · FY2010 · GM · contact PI
NEXT GENERATION SEQUENCING ADD-ON-PHARMACOGENOMICS RESEARCH NETWROK (PGRN)$7,296
U01 · FY2010 · GM · contact PI
Genomic Resources for Histoplasma capsulatum$1,500,001
U01 · FY2002 · AI
Genomic Resources for Histoplasma capsulatum$1,500,000
U01 · FY2001 · AI